Cargando…

Supraglottoplasty in neonates and infants: A radiofrequency ablation approach

BACKGROUND: Supraglottoplasty is the mainstay of surgical treatment for laryngomalacia. A novel supraglottoplasty surgical technique is needed to achieve better efficacy. The purpose of this study was to introduce modified microscopic radiofrequency ablation supraglottoplasty (MMRAS) for the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Shilei, Xu, Hongming, Li, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839815/
https://www.ncbi.nlm.nih.gov/pubmed/29443747
http://dx.doi.org/10.1097/MD.0000000000009850
_version_ 1783304469095645184
author Pu, Shilei
Xu, Hongming
Li, Xiaoyan
author_facet Pu, Shilei
Xu, Hongming
Li, Xiaoyan
author_sort Pu, Shilei
collection PubMed
description BACKGROUND: Supraglottoplasty is the mainstay of surgical treatment for laryngomalacia. A novel supraglottoplasty surgical technique is needed to achieve better efficacy. The purpose of this study was to introduce modified microscopic radiofrequency ablation supraglottoplasty (MMRAS) for the treatment of congenital laryngomalacia and to evaluate the outcome and effectiveness of this novel approach. METHODS: Seventeen children with severe laryngomalacia who underwent MMRAS were studied retrospectively. Supraglottoplasty of type III laryngomalacia was different from classical method. All the patients were kept intubated for 5 days after surgery to achieve a better epiglottal position and to avoid reconglutination of aryepiglottic folds. The patients’ demographic information, symptoms, comorbidities, type of laryngomalacia, synchronous airway lesions and final outcomes were examined. RESULTS: The median age at the time of surgery was 3.36 months (3 months 10 days). Operative indications included feeding difficulties, noisy breathing or respiratory distress (or both), and sleep-related symptoms. The MMRAS success rate was 82.4%. Most patients were extubated successfully on postoperative day 5. The major postoperative complication was pulmonary infection which occurred in 3 cases (17.6%) and required anti-infective therapy. No perioperative deaths and no long-term complications occurred. Failures were observed in 3 (17.6%) of 17 cases, 2 patients presented with a neurological disease and required tracheostomy, 1 patient relapsed because of postoperative adhesions and later underwent revision supraglottoplasty. CONCLUSIONS: From these results, we conclude that MMRAS is an effective and safe treatment for symptomatic laryngomalacia and has the potential to provide better breathing, feeding, and sleeping outcomes in children with severe laryngomalacia. Postoperative intubation for 5 days may result in better therapeutic outcomes. Multicenter cooperative studies of comparison between MMRAS and conventional approaches would lend further evidence-based support for this surgical method.
format Online
Article
Text
id pubmed-5839815
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58398152018-03-13 Supraglottoplasty in neonates and infants: A radiofrequency ablation approach Pu, Shilei Xu, Hongming Li, Xiaoyan Medicine (Baltimore) 7100 BACKGROUND: Supraglottoplasty is the mainstay of surgical treatment for laryngomalacia. A novel supraglottoplasty surgical technique is needed to achieve better efficacy. The purpose of this study was to introduce modified microscopic radiofrequency ablation supraglottoplasty (MMRAS) for the treatment of congenital laryngomalacia and to evaluate the outcome and effectiveness of this novel approach. METHODS: Seventeen children with severe laryngomalacia who underwent MMRAS were studied retrospectively. Supraglottoplasty of type III laryngomalacia was different from classical method. All the patients were kept intubated for 5 days after surgery to achieve a better epiglottal position and to avoid reconglutination of aryepiglottic folds. The patients’ demographic information, symptoms, comorbidities, type of laryngomalacia, synchronous airway lesions and final outcomes were examined. RESULTS: The median age at the time of surgery was 3.36 months (3 months 10 days). Operative indications included feeding difficulties, noisy breathing or respiratory distress (or both), and sleep-related symptoms. The MMRAS success rate was 82.4%. Most patients were extubated successfully on postoperative day 5. The major postoperative complication was pulmonary infection which occurred in 3 cases (17.6%) and required anti-infective therapy. No perioperative deaths and no long-term complications occurred. Failures were observed in 3 (17.6%) of 17 cases, 2 patients presented with a neurological disease and required tracheostomy, 1 patient relapsed because of postoperative adhesions and later underwent revision supraglottoplasty. CONCLUSIONS: From these results, we conclude that MMRAS is an effective and safe treatment for symptomatic laryngomalacia and has the potential to provide better breathing, feeding, and sleeping outcomes in children with severe laryngomalacia. Postoperative intubation for 5 days may result in better therapeutic outcomes. Multicenter cooperative studies of comparison between MMRAS and conventional approaches would lend further evidence-based support for this surgical method. Wolters Kluwer Health 2018-02-16 /pmc/articles/PMC5839815/ /pubmed/29443747 http://dx.doi.org/10.1097/MD.0000000000009850 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 7100
Pu, Shilei
Xu, Hongming
Li, Xiaoyan
Supraglottoplasty in neonates and infants: A radiofrequency ablation approach
title Supraglottoplasty in neonates and infants: A radiofrequency ablation approach
title_full Supraglottoplasty in neonates and infants: A radiofrequency ablation approach
title_fullStr Supraglottoplasty in neonates and infants: A radiofrequency ablation approach
title_full_unstemmed Supraglottoplasty in neonates and infants: A radiofrequency ablation approach
title_short Supraglottoplasty in neonates and infants: A radiofrequency ablation approach
title_sort supraglottoplasty in neonates and infants: a radiofrequency ablation approach
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839815/
https://www.ncbi.nlm.nih.gov/pubmed/29443747
http://dx.doi.org/10.1097/MD.0000000000009850
work_keys_str_mv AT pushilei supraglottoplastyinneonatesandinfantsaradiofrequencyablationapproach
AT xuhongming supraglottoplastyinneonatesandinfantsaradiofrequencyablationapproach
AT lixiaoyan supraglottoplastyinneonatesandinfantsaradiofrequencyablationapproach